Pennsylvania

Pennsylvania

State Facts

3,935

Deaths, or 83.4% o of total overdose deaths involved opioids in 2023.¹

2.4 Million

Claims, or 3.2% of all Medicare Part D claims were for opioids in 2022 – an average of 39 per prescriber.²

36.4

Opioid Prescriptions were written for every 100 persons in Pennsylvania in 2023.³

54,641

Beneficiaries on Medicare Part D had Opioid Use Disorder in 2022.⁴

Download FactSheet

Opioid Settlement Funds

$2,010,768,526.95
State Spending Recommendation

National approved use: providing support for non-opioid pain treatment alternatives, including training providers to offer or refer to multi-modal, evidence-informed treatment of pain.

Member & Endorser Footprint

Voices is backed by a broad coalition of organizations across the state united by a shared goal: ensuring patients have access to safe, effective, 
and individualized pain management throughout the continuum of care.

Co-Sponsors (119th)

Rep. Mike Kelly (R-PA-16)

Rep. Mike Kelly (R-PA-16)

Rep. GT Thompson (R-PA-15)

Rep. GT Thompson (R-PA-15)

Rep. Rob Bresnahan (R-PA-08)

Rep. Rob Bresnahan (R-PA-08)

Rep. Brian Fitzpatrick (R-PA-01)

Rep. Brian Fitzpatrick (R-PA-01)

Rep. John Joyce (R-PA-13)

Rep. John Joyce (R-PA-13)

Rep. Ryan Mackenzie (R-PA-07)

Rep. Ryan Mackenzie (R-PA-07)

Rep. Madeleine Dean (D-PA-04)

Rep. Madeleine Dean (D-PA-04)


1. Centers for Disease Control and Prevention (2024). SUDORS Dashboard: Fatal Drug Overdose Data. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/sudors-dashboard-fatal-overdose-data.html

2. Centers for Disease Control and Prevention (2024). Medicare Part D Opioid Prescribing Mapping Tool. https://cms-oeda.maps.arcgis.com/apps/MapSeries/index.html?appid=5390718d875d4c049b1ac5976a9ff083

3. Center for Disease Control and Prevention (2024). Opioid Dispensing Rate Maps. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/opioid-dispensing-rate-maps.html

4. Office of the Inspector General (2023). The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern. https://oig.hhs.gov/documents/evaluation/2722/OEI-02-23-00250-Complete%20Report.pdf